Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: Tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 273-283

  Alers, Janneke C ^a   Krijtenburg, Pieter Jaap ^a   Hop, Wim C J ^a   Bolle, Willeke A B M ^a   Schröder, Fritz H ^a   Van Der Kwast, Theodorus H ^a   Bosman, Fré T ^b   Van Dekken, Herman ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aneuploidy; Chromosomal aberrations; In situ hybridization; Metastasis; Prostatic adenocarcinoma; Tumour recurrence

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CYTOGENETICS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LONGITUDINAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER;

ADENOCARCINOMA; AGED; ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; IN SITU HYBRIDIZATION; INTERPHASE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; Y CHROMOSOME;

EID: 0031874653     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<273::AID-PATH92>3.0.CO;2-8     Document Type: Article

References (39)

1. Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol 1992; 23: 211-222.
2. Lerner SP, Seale-Hawkins C, Carlton CE, Scardino PT. The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 1991; 146: 1040-1045.
3. Stein A, deKernion JB, Smith RB, Dorey F, Patel H. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 1992; 147: 942-946.
4. Kupelian P, Katcher J, Levin H, Zippe C, Klein. Correlation of clinical and pathological factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 1996; 48: 249-260.
5. Schellhammer PF. Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 1988; 31: 191-197.
6. Humphrey PA, Frazier HA, Vollmer RT, Paulson DF. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer 1993; 71: 1821-1827.
7. Gittes RF. Carcinoma of the prostate. N Engl J Mad 1991; 324: 236-245.
8. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer 1992; 4: 16-24.
9. Arps S, Rodewald A, Scmalenberger B, Carl P, Bressel M, Kastendieck H. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 1993; 66: 93-99.
10. Vocke CD, Pozzatti RO, Bostwick DG, et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996; 56: 2411-2416.
11. Cunningham JM, Shan A, Wick MJ, et al. Allelic imbalance and micro-satellite instability in prostatic adenocarcinoma. Cancer Res 1996; 56: 4475-4482.
12. Gray IC, Philips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 1995; 55: 4800-4803.
13. Gao X, Zacharek A, Grignon DJ, et al. Localization of potential tumor suppressor loci to a <2 Mb region on chromosome 17q in human prostate cancer. Oncogene 1995; 11: 1241-1247.
14. Visakorpi T, Kallioniemi AH, Syvänen A-C, et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridizalion. Cancer Res 1995; 55: 342-347.
15. Cher ML, Bova GS, Moore DH, et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996; 56: 3091-3102.
16. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast ThH, van Dekken H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosom Cancer 1995; 12: 241-250.
17. Alers JC, Krijtenburg P-J, Vissers KJ, Krishnadath SK, Bosman FT, van Dekken H. Interphase in situ hybridization to disaggregated and intact tissue specimens of prostatic adenocarcinoma. Histochem Cell Biol 1995; 104: 479-486.
18. König JJ, Teubel W, Romijn JC, Schröder FH, Hagemeijer A. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. Hum Pathol 1996; 27: 720-727.
19. Barreton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Löhrs U. Interphase cytogenetic analysis of prostatic carcinomas by use of non-isotopic in situ hybridization. Cancer Res 1994; 54: 4474-4480.
20. Huang S-F, Xiao S, Renshaw AA, Loughlin KR, Hudson TJ, Fletcher JA. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am J Pathol 1996; 149: 1565-1573.
21. Takahashi S, Qian J, Brown JA, et al. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994; 54: 3574-3579.
22. Bandyk MG, Zhao L, Troncoso P, et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 1994; 9: 19-27.
23. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate 1992; 4 (Suppl): 129-138.
24. Brawn PN, Ayala AG, von Eschenbach AC, Hussey DH, Johnson DE. Histological grading study of prostate adenocarcinoma. The development of a new system and comparison with other methods-a preliminary study. Cancer 1982; 49: 525-532.
25. Alers JC, van Dekken H. Interphase cylogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization. Prog Histochem Cytochem Ser 1996; 36: 1-137.
26. Alers JC, Krijtenburg P-J, Rosenberg C, et al. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 1997; 77: 437-448..
27. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. Comparalive genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 1994; 11: 153-162.
28. Noordzij MA, van Weerden WM, de Ridder CMA, van der Kwast ThH, Schröder GJ. Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol 1996; 149: 859-871.
29. Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation. Cancer Genet Cytogenet 1995; 80: 40-46.
30. Fujiwara Y, Monden M, Mori T, Nakamura Y, Emi M. Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 1993; 53: 857-860.
31. Isola JJ, Kallioniemi O-P, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995; 147: 905-911.
32. Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991; 51: 3807-3813.
33. Collard JG, van de Poll M, Scheffer A, et al. Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res 1987; 47: 6666-6670.
34. Alers JC, Krijtenburg PJ, Vissers CJ, Bosnian FT, van der Kwast ThH, van Dekken H. Cytogenetic heterogeneity and histologic tumor growth patterns in prostatic cancer. Cytometry 1995; 21: 84-94.
35. O'Malley FP, Grignon DJ, Keeney M, Kerkvliet N, McLean C. DNA heterogeneity in prostatic adenocarcinoma. Cancer 1993; 71: 2797-2802.
36. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28.
37. Sakr WA, Macoska JA, Benson P, et al. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 1994; 54: 3273-3277.
38. Van den Ouden D, Tribukait B, Blom JHM, et al. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. J Urol 1993; 150: 400-406.
39. Ross JS, Figge H, Bui HX, et al. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer. Cancer 1994; 74: 2811-2818.